The Procter & Gamble Company;The Cleveland Clinic Foundation
发明人:
Hazen, Stanley Leon,Garcia-Garcia, Jose Carlos,Gerberick, George Franklin,Wos, John August,Stanton, David Thomas,Inglin, Thomas Alfred,Reilly, Michael,Deutsch, Angela Jane,Reed, Jodie Michelle,Cody, D
申请号：
AU2016365314
公开号：
AU2016365314A1
申请日:
2016.12.01
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention provides one or more methods of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I) wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline in the individual.
